Know Cancer

or
forgot password

Immunotherapy of Colon Cancer With Autologous Perchloric Soluble Tumors Extracts


Phase 3
20 Years
80 Years
Open (Enrolling)
Both
Breast Cancer, Colorectal Cancer, Melanoma (Skin)

Thank you

Trial Information

Immunotherapy of Colon Cancer With Autologous Perchloric Soluble Tumors Extracts


OBJECTIVES:

- Determine the survival of patients with colon cancer, breast cancer, or melanoma with
minimal residual disease after surgical resection treated with maintenance
immunotherapy using Corynebacterium granulosum P40.

- Determine leucocyte adherence inhibition, an indication of metastases, over time in
patients treated with this regimen.

OUTLINE: This is a multicenter study. Patients are stratified by center and are matched with
case-controls by disease type and stage.

Beginning 2 weeks after surgical resection, patients receive Corynebacterium granulosum P40
subcutaneously weekly for 6 weeks, followed by rest for 3 months. Treatment continues for
life.

Patients are followed for survival.

PROJECTED ACCRUAL: Not specified

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of colon cancer, breast cancer, or melanoma with minimal residual disease
(at least 90% of tumor mass resected) after surgical resection

- Hormone receptor status:

- Not specified

PATIENT CHARACTERISTICS:

Age:

- 20 to 80

Sex:

- Not specified

Menopausal status:

- Not specified

Performance status:

- Not specified

Life expectancy:

- Not specified

Hematopoietic:

- Not specified

Hepatic:

- Not specified

Renal:

- Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy

- Not specified

Chemotherapy

- Not specified

Endocrine therapy

- Not specified

Radiotherapy

- Not specified

Surgery

- See Disease Characteristics

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Outcome Measure:

Recurrence

Safety Issue:

No

Principal Investigator

Hugo Omar De Carli, MD

Investigator Role:

Study Chair

Investigator Affiliation:

Centro Oncologico de Excelencia

Authority:

United States: Federal Government

Study ID:

CDR0000072435

NCT ID:

NCT00002455

Start Date:

April 1971

Completion Date:

Related Keywords:

  • Breast Cancer
  • Colorectal Cancer
  • Melanoma (Skin)
  • stage I colon cancer
  • stage II colon cancer
  • stage III colon cancer
  • stage I breast cancer
  • stage II breast cancer
  • stage IIIA breast cancer
  • recurrent breast cancer
  • recurrent colon cancer
  • stage I melanoma
  • stage II melanoma
  • stage III melanoma
  • recurrent melanoma
  • Breast Neoplasms
  • Colonic Neoplasms
  • Colorectal Neoplasms
  • Melanoma

Name

Location